Skip to content
Governance Register

← US public companies

Talecris Biotherapeutics Holdings Corp.

SEC CIK 1405197 · v9sns*ij · last insider filing 2011-06-03

Directors (from insider filings)

NameCapacity as filedFilings
Charpie Richard A Director filed 2009 - 2011
Ingersoll W Brett Director filed 2009 - 2011
Martin Kenneth J Director filed 2009 - 2011
Lenehan James T Director filed 2009 - 2011
Mitchell Dean J Director filed 2009 - 2011
Clark Paul N Director filed 2009 - 2011
Mayer Steven F Director filed 2009 - 2011
Waeger Ruedi E Director filed 2009 - 2011
Stern Lawrence D Director · Chairman and CEO filed 2009 - 2011
Auerbach Stuart A Director filed 2009 - 2009

Officers (from insider filings)

NameTitle as filedFilings
Gaither John F JR Exec.VP,General Counsel, Secy. filed 2009 - 2011
Lynch Thomas J Sr. VP, Corp. Compliance filed 2009 - 2011
Kuhn Mary J Executive VP, Operations filed 2009 - 2011
Abelson Joel E Sr VP & GM, Port & Int. Bus filed 2009 - 2011
Engle James R Sr. VP, Information Technology filed 2009 - 2011
Hanson John M Executive VP and CFO filed 2009 - 2011
Heerdt Kari D Sr. VP, Human Resources filed 2009 - 2011
Nogales Bruce Sr. VP & GM, Plasma Resources filed 2009 - 2011
Petteway Stephen R Jr Executive VP, R&D filed 2009 - 2011
Perkins John R II Sr.VP & GM, Portfolio & US Bus filed 2009 - 2011
Menichella Daniel L Sr. VP, Business Development filed 2009 - 2011

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.